<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Epidemiology and etiology of premenopausal osteoporosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Epidemiology and etiology of premenopausal osteoporosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Epidemiology and etiology of premenopausal osteoporosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carolyn B Becker, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Adi Cohen, MD, MHS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Clifford J Rosen, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Katya Rubinow, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 11, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Osteoporosis is a skeletal condition characterized by low bone mass, which is associated with reduced bone strength and an increased risk of fractures. Osteoporosis occurs most commonly in postmenopausal women. Numerous guidelines and recommendations exist regarding the evaluation and management of osteoporosis in this population. Male osteoporosis has also gained attention as a growing public health concern. Postmenopausal osteoporosis and osteoporosis in men are reviewed separately. (See  <a class="medical medical_review" href="/d/html/2035.html" rel="external">"Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women"</a> and  <a class="medical medical_review" href="/d/html/2064.html" rel="external">"Overview of the management of low bone mass and osteoporosis in postmenopausal women"</a> and  <a class="medical medical_review" href="/d/html/2049.html" rel="external">"Etiology of osteoporosis in men"</a>.)</p><p>Both fractures and low bone mass are less common in premenopausal women. Low bone mass, when present, may be related to either inadequate peak bone mass acquisition and/or ongoing bone loss. Bone loss and/or fractures can often be attributed to a secondary cause such as estrogen deficiency, glucocorticoid exposure, or hyperparathyroidism. The term idiopathic osteoporosis (IOP) is reserved for the subset of women with no apparent etiology or known secondary cause. Some women with IOP may have an adult presentation of a primary or genetic etiology of bone fragility [<a href="#rid1">1,2</a>].</p><p>The diagnosis of osteoporosis and guidelines for treatment of osteoporosis based upon bone mass in postmenopausal women do not generally apply to premenopausal women, as the relationship between bone mass and fracture risk in premenopausal women is not the same as in postmenopausal women.</p><p>This topic reviews the definition, epidemiology, and etiology of premenopausal osteoporosis. Evaluation and management will be reviewed separately. (See  <a class="medical medical_review" href="/d/html/2060.html" rel="external">"Evaluation and treatment of premenopausal osteoporosis"</a>.) </p><p class="headingAnchor" id="H2"><span class="h1">DEFINITIONS</span></p><p class="headingAnchor" id="H3"><span class="h2">Low bone mass</span><span class="headingEndMark"> — </span>The measurement of bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA) is used as an index of bone strength and fracture risk, and it can be used to diagnose osteoporosis in some populations, such as postmenopausal women. The World Health Organization (WHO) defines osteoporosis in postmenopausal women as a BMD value at the spine, hip, or forearm of 2.5 or more standard deviations (SD) below the young adult mean (T-score ≤-2.5), with or without the presence of a fragility fracture [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/d/html/2035.html" rel="external">"Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women"</a> and  <a class="medical medical_review" href="/d/html/2056.html" rel="external">"Overview of dual-energy x-ray absorptiometry"</a>.)</p><p>In premenopausal women, the prevalence of fractures is much lower compared with postmenopausal women, and the relationship between BMD and fracture risk is not the same. Thus, neither the diagnostic guidelines nor the treatment practices based on BMD measurements in postmenopausal women can apply to this younger population. Similarly, the Fracture Risk Assessment (FRAX) tool cannot be used to evaluate fracture risk based on BMD in premenopausal women. The International Society for Clinical Densitometry (ISCD) recommends use of BMD Z-scores (comparison with age-matched norms) at the lumbar spine, total hip, femoral neck, and distal radius, rather than T-scores, and avoidance of the term osteopenia [<a href="#rid4">4</a>]. The use of Z-scores in this population helps to avoid application of the postmenopausal diagnostic and therapeutic implications of the T-score. A Z-score ≤-2.0 should be interpreted as "below the expected range for age" [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/d/html/2035.html" rel="external">"Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women"</a> and  <a class="medical medical_review" href="/d/html/2056.html" rel="external">"Overview of dual-energy x-ray absorptiometry"</a>.)</p><p>BMD measurements alone should not be used to define osteoporosis in premenopausal women [<a href="#rid5">5,6</a>]. According to the ISCD, a young woman with low BMD for age (Z-score ≤-2.0) and with risk factors for fracture or secondary causes of osteoporosis (such as glucocorticoid therapy, hypogonadism, or hyperparathyroidism) may be defined as having premenopausal osteoporosis [<a href="#rid4">4</a>]. However, in contrast to ISCD, the International Osteoporosis Foundation (IOF) recommends use of T-scores in those aged 20 to 50 years and suggests use of T-score &lt;-2.5 to define osteoporosis, particularly in those with known secondary causes or in the context of low-trauma fractures that provide evidence of bone fragility [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Low-trauma fracture</span><span class="headingEndMark"> — </span>Premenopausal women may come to medical attention because of a fragility fracture. As in all cases of unusual fracture, the diagnosis of osteoporosis should be considered only after osteomalacia (undermineralization due to causes such as severe vitamin D deficiency or hypophosphatemia) and other causes of pathological fracture (eg, malignancy, avascular necrosis, fibrous dysplasia, other bone lesion) have been ruled out. After ruling out these pathologies, any fracture in an adult woman (aside from a fracture of the digits, skull, or face) that occurs from a standing height or less, without major trauma such as a motor vehicle accident, can be considered a low-trauma or fragility fracture. Such women may have decreased bone strength. Premenopausal women with a history of low-trauma fracture at sites such as the spine, hip, pelvis, humerus, or forearm may be considered to have osteoporosis, irrespective of BMD.</p><p class="headingAnchor" id="H5"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H6"><span class="h2">Low bone mass</span><span class="headingEndMark"> — </span>Low bone mass is less common in premenopausal women compared with postmenopausal women and, when present, may be related to either inadequate peak bone mass acquisition, or previous or continuing bone loss.</p><p>The clinical significance of isolated low bone density (without fracture) in young women is unknown. Some premenopausal women with low bone mineral density (BMD), particularly those with a known secondary cause of osteoporosis, may have abnormal bone strength that may lead to an increased risk of fracture. Currently, available data do not allow us to predict fracture risk in premenopausal women with low bone density and no known secondary cause. One longitudinal study has documented stable BMD and a low short-term risk of fractures in this population [<a href="#rid8">8</a>]. However, in a study of premenopausal women with idiopathic osteoporosis (IOP; unexplained low BMD or low-trauma fracture), high-resolution peripheral quantitative computed tomography (HRpQCT) [<a href="#rid9">9</a>] and analyses of transiliac biopsy samples [<a href="#rid10">10</a>] showed comparable microarchitectural deterioration in the low BMD and fracture groups compared with controls [<a href="#rid9">9</a>]. These findings suggest that asymptomatic low BMD is associated with structural abnormalities that would predict lower bone strength. Even so, because of a lack of prospective data relating BMD to fracture risk, BMD alone cannot be used to determine osteoporosis diagnosis or treatment in premenopausal women.</p><p class="headingAnchor" id="H7"><span class="h3">Peak bone mass acquisition</span><span class="headingEndMark"> — </span>BMD in premenopausal women depends primarily upon achievement of peak bone mass. Low BMD in a premenopausal woman may result from the attainment of a peak bone mass that is below average due to genetic predisposition, illnesses, or medications that negatively impact bone density accrual. "Peak bone mass" is usually defined as the maximum BMD achieved by age 30 to 40 years, as measured by dual-energy x-ray absorptiometry (DXA) [<a href="#rid11">11,12</a>].</p><p>In healthy girls, the peak period of bone mass accrual occurs between ages 11 and 14 years [<a href="#rid13">13</a>]. Although 95 to 100 percent of peak bone mass is acquired by the late teen years [<a href="#rid13">13-15</a>], studies have documented continued small gains occurring between the ages of 20 and 29 years [<a href="#rid16">16</a>]. Population-based, cross-sectional studies suggest that women attain peak bone mass at the proximal femur in their 20s and at the spine and forearm around age 30 years [<a href="#rid17">17,18</a>].</p><p>Attainment of peak bone mass varies according to sex, ethnicity, body size, and region of bone [<a href="#rid12">12</a>]. Thus, when interpreting BMD measurements in premenopausal women, the possibility that peak bone mass has not yet been achieved must always be considered. (See  <a class="medical medical_review" href="/d/html/2044.html" rel="external">"Pathogenesis of osteoporosis", section on 'Peak bone mass acquisition'</a>.)</p><p class="headingAnchor" id="H8"><span class="h3">Perimenopausal bone loss</span><span class="headingEndMark"> — </span>Bone loss begins prior to menopause, as illustrated by several prospective studies [<a href="#rid19">19-28</a>] that have reported varying degrees of bone loss during the menopausal transition, more often in women with subclinical ovulation disturbances or perimenopausal symptoms [<a href="#rid29">29,30</a>].</p><p>In a longitudinal, multiethnic cohort study of 862 women followed for 10 years, the annual rates and cumulative amounts of BMD loss were greater one year prior through two years after the final menstrual period (transmenopause) than those occurring between two and five years after the final menstrual period (postmenopause) [<a href="#rid31">31</a>]. Cumulative 10-year and transmenopause BMD loss was 10.6 and 7.4 percent, respectively, at the lumbar spine and 9.1 and 5.8 percent, respectively, at the femoral neck. Higher body mass index (BMI) was associated with slower bone loss. The adverse effect of low body weight on bone loss during the menopausal transition was similarly reported in a study of 896 perimenopausal women followed for a mean of six years [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Fractures</span></p><p class="headingAnchor" id="H1252549052"><span class="h3">Relationship to BMD</span><span class="headingEndMark"> — </span>Premenopausal women generally have much lower rates of fracture than postmenopausal women [<a href="#rid33">33-37</a>]. As in postmenopausal women, however, young women with lower BMD tend to have the greatest risk for fractures [<a href="#rid38">38-40</a>]. In two studies of premenopausal women with Colles' fractures, BMD at the nonfractured radius [<a href="#rid41">41</a>], lumbar spine, and femoral neck [<a href="#rid42">42</a>] were significantly below age-matched peers. In another study comparing premenopausal women with a distal radius fracture with controls, BMD (DXA) was similar at these sites; however, there was evidence of trabecular microarchitectural deterioration (as measured by HRpQCT) at both the distal radius and distal tibia in the women with fracture [<a href="#rid43">43</a>]. Stress fractures, a distinct fracture type associated with repeated mechanical stress, rather than acute injury, are particularly common among certain groups of young women including professional dancers, military recruits, and female athletes. Stress fractures have been associated with lower BMD in some studies [<a href="#rid44">44-52</a>], but not others [<a href="#rid53">53</a>]. Studies using analyses of images obtained via HRpQCT of the radius and tibia have also documented trabecular microarchitectural deficiencies in premenopausal women with fractures, in comparison with controls [<a href="#rid54">54-56</a>]. (See  <a class="medical medical_review" href="/d/html/255.html" rel="external">"Overview of stress fractures"</a> and  <a class="medical medical_review" href="/d/html/7393.html" rel="external">"Functional hypothalamic amenorrhea: Pathophysiology and clinical manifestations"</a>.)</p><p>Vertebral fractures can occur despite normal BMD in women receiving glucocorticoids. One study found that 7 of 16 premenopausal women treated with high-dose glucocorticoids had evidence of vertebral fractures despite normal BMD [<a href="#rid57">57</a>]. Vertebral fractures in premenopausal women may go undetected unless radiographs or vertebral assessment measurements are performed. In certain high-risk populations, such as young women with autoimmune disorders on high doses of glucocorticoids, the prevalence of vertebral fractures may be as high as 21 percent [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H10"><span class="h3">Later risk</span><span class="headingEndMark"> — </span>A history of premenopausal fracture significantly increases the risk of a postmenopausal fracture. Data from the Study of Osteoporotic Fractures (SOF) demonstrate that women with a history of premenopausal fracture are 35 percent more likely to fracture during the postmenopausal years compared with women without a history of premenopausal fracture [<a href="#rid35">35</a>]. This relationship persists after controlling for a number of potential confounding variables. Other studies have reported similar findings [<a href="#rid35">35,36,59,60</a>]. These findings suggest that the risk of sustaining fractures may be a lifelong trait, probably reflecting the interaction of an individual's bone mass, bone quality, fall frequency, and neuromuscular protective response to falls [<a href="#rid36">36</a>].</p><p class="headingAnchor" id="H11"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>In premenopausal women, low bone mass and/or low-trauma fractures can sometimes be attributed to a secondary cause such as estrogen deficiency, glucocorticoid exposure, malabsorption, or hyperparathyroidism  (<a class="graphic graphic_table graphicRef64403" href="/d/graphic/64403.html" rel="external">table 1</a>).</p><p>Low bone mass may be related to either inadequate peak bone mass acquisition and/or ongoing bone loss. Premenopausal women with low bone mass, no history of adult fracture, and no known secondary cause may or may not have a defect in bone strength.</p><p class="headingAnchor" id="H13"><span class="h2">Secondary causes</span><span class="headingEndMark"> — </span>Some of the more common conditions that may cause low bone mass and/or fracture include the following:</p><p class="headingAnchor" id="H14"><span class="h3">Estrogen deficiency</span><span class="headingEndMark"> — </span>Premenopausal estrogen deficiency from any cause is associated with bone loss or inadequate peak bone mass accrual. Examples include:</p><p class="bulletIndent1"><span class="glyph">●</span>Hypogonadotropic hypogonadism due to low weight, eating disorders, relative energy deficiency in sports (RED-S), hyperprolactinemia, and hypopituitarism. (See  <a class="medical medical_review" href="/d/html/7393.html" rel="external">"Functional hypothalamic amenorrhea: Pathophysiology and clinical manifestations"</a> and  <a class="medical medical_review" href="/d/html/2093.html" rel="external">"Eating disorders: Overview of epidemiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6638.html" rel="external">"Clinical manifestations and evaluation of hyperprolactinemia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypergonadotropic hypogonadism (premature ovarian insufficiency) due to various etiologies including chromosomal abnormalities such as Turner syndrome and fragile X syndrome, toxins such as chemotherapy and radiation, and autoimmune disease. (See  <a class="medical medical_review" href="/d/html/7426.html" rel="external">"Management of primary ovarian insufficiency (premature ovarian failure)"</a> and  <a class="medical medical_review" href="/d/html/7391.html" rel="external">"Clinical manifestations and diagnosis of Turner syndrome", section on 'Osteoporosis and bone health'</a> and  <a class="medical medical_review" href="/d/html/2060.html" rel="external">"Evaluation and treatment of premenopausal osteoporosis"</a>.)</p><p></p><p class="headingAnchor" id="H15"><span class="h3">Drugs</span><span class="headingEndMark"> — </span>Drugs that may be associated with bone loss in premenopausal women include glucocorticoids, some anticonvulsants, and depot <a class="drug drug_general" data-topicid="9600" href="/d/drug information/9600.html" rel="external">medroxyprogesterone acetate</a>. (See  <a class="medical medical_review" href="/d/html/2032.html" rel="external">"Clinical features and evaluation of glucocorticoid-induced osteoporosis"</a> and  <a class="medical medical_review" href="/d/html/2036.html" rel="external">"Drugs that affect bone metabolism"</a>.)</p><p class="headingAnchor" id="H16"><span class="h3">Other</span><span class="headingEndMark"> — </span>Many of the other risk factors for premenopausal osteoporosis are similar to those for postmenopausal osteoporosis and osteoporosis in men, including  (<a class="graphic graphic_table graphicRef64403" href="/d/graphic/64403.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Smoking.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inflammatory bowel disease. (See  <a class="medical medical_review" href="/d/html/2028.html" rel="external">"Metabolic bone disease in inflammatory bowel disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Celiac disease. (See  <a class="medical medical_review" href="/d/html/4774.html" rel="external">"Epidemiology, pathogenesis, and clinical manifestations of celiac disease in adults", section on 'Metabolic bone disorders'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cystic fibrosis. (See  <a class="medical medical_review" href="/d/html/6367.html" rel="external">"Cystic fibrosis: Clinical manifestations and diagnosis", section on 'Musculoskeletal disorders'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Previous or current hyperthyroidism. (See  <a class="medical medical_review" href="/d/html/7882.html" rel="external">"Bone disease with hyperthyroidism and thyroid hormone therapy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypercalciuria [<a href="#rid61">61</a>]. (See  <a class="medical medical_review" href="/d/html/7375.html" rel="external">"Kidney stones in adults: Epidemiology and risk factors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyperparathyroidism. (See  <a class="medical medical_review" href="/d/html/2031.html" rel="external">"Primary hyperparathyroidism: Clinical manifestations", section on 'Skeletal'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Depression has been associated with low bone mineral density (BMD) in premenopausal women [<a href="#rid62">62-64</a>]. However, the relationship between depression and osteoporosis is likely complex. Individuals with depression may have other risk factors for low bone mass, including medication use (antidepressants), hypercortisolism, and lifestyle factors including lower physical activity.</p><p></p><p class="headingAnchor" id="H17"><span class="h2">Normal pregnancy and lactation</span><span class="headingEndMark"> — </span>Some studies suggest that pregnancy is associated with bone losses of approximately 3 to 5 percent at the spine and hip [<a href="#rid65">65-67</a>], while other studies have found that bone density remains stable during this period of increased calcium demand [<a href="#rid68">68</a>], or declines significantly only at the trochanter [<a href="#rid69">69</a>].</p><p>In contrast, lactation has more consistent and profound effects on bone density [<a href="#rid70">70</a>]. Bone loss of 3 to 10 percent at the spine and hip are seen over three to six months of lactation [<a href="#rid67">67,71</a>]. Bone loss is related to duration of lactation and duration of amenorrhea and is not prevented by calcium supplementation [<a href="#rid72">72-74</a>].</p><p>Parathyroid hormone-related protein (PTHrP), which is secreted by the lactating mammary gland, plays an important role in the control of calcium mobilization from bone during lactation in both humans and animals [<a href="#rid70">70,75,76</a>]. Estrogen deficiency that is characteristic of lactation may also be involved in the control of bone loss during this time.</p><p>Bone loss reverses during and after weaning [<a href="#rid70">70</a>]. Longitudinal studies in postpartum women show that recovery from lactation-associated bone loss may continue for 18 months or longer [<a href="#rid73">73,77</a>]. Studies in both humans and animal models suggest that the pattern and extent of bone recovery may be site specific, with complete reversal at the spine but incomplete or slower recovery at other sites [<a href="#rid78">78</a>]. Studies in animal models have also suggested that reproductive events lead to lasting microstructural skeletal changes that may be protective in the context of future menopausal bone loss [<a href="#rid79">79</a>]. Of note, most studies (including an analysis of data from the Women's Health Initiative Observational Study, sample size over 92,000) have not found an association between either parity (number of births) or lactation and osteoporosis or increased fracture risk in postmenopausal women in the United States or northern Europe [<a href="#rid80">80-84</a>].</p><p>These reproduction-related changes affect interpretation of bone density results. Care must be taken to obtain a detailed history regarding recent pregnancies and duration of lactation when interpreting bone density in a parous premenopausal woman. When bone density measurements are obtained around the time of pregnancy or lactation, it may be difficult to separate physiologic from pathophysiologic changes.</p><p class="headingAnchor" id="H18"><span class="h2">Pregnancy and lactation-associated osteoporosis</span><span class="headingEndMark"> — </span>Pregnancy and lactation-associated osteoporosis (PLO) is a rare condition in which women typically present with painful fractures, often vertebral, in the third trimester of pregnancy or in the early postpartum period [<a href="#rid85">85,86</a>]. In a minority of cases, presentation with femoral neck fracture(s) during or after pregnancy has been described [<a href="#rid87">87,88</a>]. The overall incidence is estimated to be 0.4 cases per 100,000 women [<a href="#rid70">70</a>]. However, in a 20-year retrospective analysis of all cases of PLO (n = 16) at a single institution in Scotland, the incidence of PLO was estimated to be 6.8 cases per 100,000 pregnancies [<a href="#rid89">89</a>].</p><p>Several cohort studies documenting the clinical characteristics of PLO have reported that approximately 70 percent of women are primiparous and &gt;75 percent have vertebral fractures, with an average of four to five fractures at presentation [<a href="#rid86">86,87,89-93</a>]. In a survey of 177 women with PLO, 93 percent reported vertebral fractures, with symptom onset during lactation in 79 percent and occurring on average at two months postpartum [<a href="#rid87">87</a>]. Several studies have documented very low BMD at the time of PLO presentation, with spine dual-energy x-ray absorptiometry (DXA) T- and Z-scores &lt;-3.0 [<a href="#rid86">86,87,92,93</a>].</p><p>As this disorder is likely to be heterogeneous in its etiology and prognosis, a thorough evaluation for secondary causes of osteoporosis should be undertaken in all cases of PLO.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Potential mechanisms and etiologies</strong> – Skeletal fragility in PLO may result from abnormal pregnancy-related changes in bone. Alternatively, women with preexisting skeletal fragility may manifest with fractures in the setting of the skeletal stress associated with a pregnancy and lactation [<a href="#rid94">94,95</a>]. </p><p></p><p class="bulletIndent1">Data from microarchitectural studies are consistent with the clinical presentation that commonly involves fractures at trabecular sites. In a study of seven primiparous women with PLO fractures, high-resolution peripheral quantitative computed tomography (HRpQCT) measurements showed marked trabecular microarchitectural deficits compared with healthy lactating controls [<a href="#rid96">96</a>].</p><p></p><p class="bulletIndent1">The majority of case reports and case series find no known cause of osteoporosis in most women [<a href="#rid87">87,90,91</a>]. However, in a retrospective study of 52 women with PLO in France, 35 women (67 percent) had risk factors for low bone density either before or during the pregnancy [<a href="#rid92">92</a>]. Another retrospective cohort study found that 60 percent of women with PLO (10 of 16) had taken at least one medication that can contribute to osteoporosis, including low-molecular weight heparin and glucocorticoids [<a href="#rid89">89</a>]. In a survey study of 177 women with PLO, both heparin exposure (reported by 18 percent) and celiac disease (reported by 6 percent) were associated with more severe disease presentation [<a href="#rid87">87</a>].</p><p></p><p class="bulletIndent1">An investigation of first-degree relatives of patients with PLO has suggested a strong genetic component [<a href="#rid97">97</a>], and family history of osteoporosis is reported by 30 to 50 percent of patients [<a href="#rid87">87,89,92</a>]. In a cohort of 42 women with PLO, gene panel screening found heterozygous variants classified as disease causing in eight women (19 percent) and heterozygous variants of interest in 21 (50 percent) [<a href="#rid98">98</a>]. Variants classified as disease causing were found in <em>LRP5, WNT1, ALPL, COL1A1, COL1A2, </em>and<em> SLC34A3</em>. Other studies have also documented variants in <em>LRP5 </em>and<em> PLS3</em> in women with PLO [<a href="#rid2">2,99,100</a>].</p><p></p><p class="bulletIndent1">It is notable that several variants found (<em>LRP5, WNT1</em>) are associated with a low bone turnover state. In a study examining bone remodeling rate at the tissue level (transiliac crest bone biopsies), women with PLO (studied more than one year postpartum at a time point that should reflect their baseline bone remodeling state) were found to have significantly lower bone remodeling rate in comparison with other premenopausal women with unexplained fractures and in comparison with healthy controls [<a href="#rid101">101</a>]. These findings suggest that abnormal osteoblast function or other bone formation defects may contribute to the pathophysiology of PLO.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Long-term outcomes</strong> – Although some longitudinal studies report increases in spine and hip BMD over several years after the index pregnancy in women not receiving bone-specific therapy [<a href="#rid102">102</a>], studies also show an increased risk of fracture recurrence (overall and within the context of another pregnancy) [<a href="#rid90">90</a>]. In a study including 107 patients with PLO followed for a median of six years, 24 percent had subsequent fractures; the great majority of subsequent fractures were vertebral fractures, and number of fractures at diagnosis predicted subsequent risk [<a href="#rid90">90</a>]. Another study with 16.3-year follow-up of 20 women with PLO (average number of fractures 5.4) found that only 3 of the 20 women (15 percent) had subsequent fractures but all had severe physical and psychological distress at presentation. By two years after the fractures, symptoms had lessened but the majority of women were unable to return to work for 3.3 years [<a href="#rid103">103</a>]. Findings from a social media survey suggest that psychological stress from PLO can endure for many years. Participants in an online support group for women with PLO were compared with a control group of women without PLO using an online questionnaire. Most women with PLO expressed fear of fractures (18 of 24, or 67 percent) and fear of falling (15 of 24, or 56 percent) compared with only 0 and 2 percent of women, respectively, in the control group. Time from last pregnancy ranged from a few months up to eight years postpartum in both groups [<a href="#rid104">104</a>].</p><p></p><p class="headingAnchor" id="H20"><span class="h2">Idiopathic osteoporosis</span><span class="headingEndMark"> — </span>Young women with bone fragility who lack secondary causes and disturbances in calcium metabolism are said to have "idiopathic osteoporosis" (IOP).</p><p>Two reports of IOP described the following clinical features [<a href="#rid61">61,105</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Females and males were affected equally.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A family history of osteoporosis was common.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The mean age at diagnosis was approximately 35 years old.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fractures were usually multiple, occurring over a 5- to 10-year period, and involving sites rich in cancellous bone, such as the vertebrae. The hip was affected in approximately 10 percent of cases.</p><p></p><p>IOP is likely to be a heterogeneous disorder. Proposed mechanisms include osteoblast dysfunction and other forms of primary osteoporosis, abnormalities in the growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis, subclinical estrogen deficiency, increased bone turnover, and hypercalciuria [<a href="#rid10">10,61,105-110</a>]. In a report of bone biopsy samples from women with IOP, bone remodeling was heterogeneous, with high, normal, and low bone formation rates seen [<a href="#rid10">10</a>]. Some women with IOP may have an unknown cause of bone loss and exhibit rapid bone metabolism, whereas others, with low bone formation rate, may have bone fragility due to inadequate peak bone mass acquisition without an active process of bone loss.</p><p>Among the women studied, those with the lowest bone formation rate had the most profound microarchitectural abnormalities. In one study of women with IOP, low bone formation rates were associated with higher body fat and higher IGF-1 levels [<a href="#rid111">111</a>]. The IGF-1 finding was unexpected since other forms of low turnover osteoporosis are associated with low IGF-1. The unexpected and paradoxical relationship between bone turnover and IGF-1 led to the hypothesis that atypical regulation of bone and fat may contribute to the mechanisms of osteoporosis in some women with IOP [<a href="#rid111">111</a>].</p><p class="headingAnchor" id="H2643684595"><span class="h2">Genetic causes/primary osteoporosis</span><span class="headingEndMark"> — </span>Some premenopausal women with unexplained fractures may represent a later presentation of a primary form of osteoporosis. Several conditions associated with abnormal skeletal development and bone fragility in childhood can have widely variable clinical presentations and degrees of severity. In rare instances, these conditions may lead to symptoms and/or diagnosis in early adulthood rather than childhood. Such conditions include osteogenesis imperfecta [<a href="#rid112">112</a>], hypophosphatasia (associated with osteomalacia), osteoporosis-pseudoglioma syndrome [<a href="#rid99">99,100</a>]/<em>LRP5</em> mutations [<a href="#rid113">113</a>], Marfan syndrome, and Ehlers-Danlos syndrome. Age at presentation, severity of disease, and other clinical features may lead to evaluation for such primary causes of osteoporosis/fracture. (See  <a class="medical medical_review" href="/d/html/8150.html" rel="external">"Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders"</a> and  <a class="medical medical_review" href="/d/html/14920.html" rel="external">"Clinical manifestations and diagnosis of Ehlers-Danlos syndromes"</a> and  <a class="medical medical_review" href="/d/html/2943.html" rel="external">"Osteogenesis imperfecta: An overview"</a>.)</p><p>Mutational analysis in women with PLO, or in females and males with IOP presenting in young adulthood, has revealed rare or novel mutations (eg, <em>LRP5/LRP6</em>, <em>COL1A1</em>, and <em>COL1A2, PLS3</em>, <em>WNT1</em>, <em>DKK1, FKBP10, HGD, SLC34A3)</em> in selected patients [<a href="#rid1">1,2,114,115</a>]. In a whole exome sequencing study including 75 women with IOP or idiopathic low BMD, four women had likely pathogenic heterozygous variants found in <em>LRP5</em> and <em>PLS3</em> and four additional women had heterozygous variants of uncertain significance in <em>FKBP10</em>, <em>SLC34A3,</em> and <em>HGD</em>. The genetic findings are consistent with heterogeneous mechanisms for IOP; some findings were associated with very low bone remodeling while others were associated with high bone turnover and hypercalciuria or renal stones. It is also notable that no pathogenic genetic variants were found by whole exome sequencing in 89 percent of the subjects [<a href="#rid2">2</a>]. Further research is needed to identify additional genetic and nongenetic etiologies of IOP.</p><p class="headingAnchor" id="H1531222098"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/105492.html" rel="external">"Society guideline links: Osteoporosis"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – The relationship between fracture and low bone mass in premenopausal women is less certain than in postmenopausal women. Thus, the bone mineral density (BMD) criteria for diagnosis of osteoporosis in postmenopausal women do not generally apply to premenopausal women. Premenopausal women with a low-trauma fracture (aside from a fracture of the digits, skull, or face) may be considered to have osteoporosis (irrespective of BMD) only after other causes of fracture (eg, osteomalacia due to severe vitamin D deficiency, malignancy, other bone lesion) are excluded. (See <a class="local">'Definitions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Low bone mass in premenopausal women may be due to suboptimal peak bone mass acquisition, ongoing bone loss, or both. The clinical significance of isolated low bone density in young women is unknown. However, a history of fracture in a premenopausal woman is associated with an increased risk of fracture later in life. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Secondary causes</strong> – Low bone mass and/or low-trauma fractures in premenopausal women are usually attributable to other conditions (secondary causes) that predispose to osteoporosis. (See <a class="local">'Secondary causes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy and lactation-associated osteoporosis</strong> – Pregnancy and lactation are states of high calcium demand and are associated with substantial expected and physiologic changes in bone mass. In some premenopausal women, early-onset osteoporosis presents in the context of the skeletal stress associated with pregnancy and lactation. This presentation is called pregnancy and lactation-associated osteoporosis (PLO). (See <a class="local">'Pregnancy and lactation-associated osteoporosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Idiopathic osteoporosis</strong> – Idiopathic osteoporosis (IOP) describes the condition of low trauma fracture(s) in premenopausal women in the absence of an identifiable primary or secondary cause. Proposed mechanisms include osteoblast dysfunction, abnormalities in the growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis, subclinical estrogen deficiency, increased bone turnover, and hypercalciuria. (See <a class="local">'Idiopathic osteoporosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetic causes</strong> – In some cases, early-onset osteoporosis in a premenopausal woman may be related to primary or genetic forms of osteoporosis presenting in adulthood. Several studies have investigated potential genetic etiologies of both IOP and PLO. (See <a class="local">'Genetic causes/primary osteoporosis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Collet C, Ostertag A, Ricquebourg M, et al. Primary Osteoporosis in Young Adults: Genetic Basis and Identification of Novel Variants in Causal Genes. JBMR Plus 2018; 2:12.</a></li><li><a class="nounderline abstract_t">Cohen A, Hostyk J, Baugh EH, et al. Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis. Bone 2022; 154:116253.</a></li><li><a class="nounderline abstract_t">Kanis JA, Melton LJ 3rd, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9:1137.</a></li><li class="breakAll">https://www.iscd.org/official-positions/2019-iscd-official-positions-adult/ (Accessed on July 08, 2019).</li><li><a class="nounderline abstract_t">Pepe J, Body JJ, Hadji P, et al. Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF. J Clin Endocrinol Metab 2020; 105.</a></li><li><a class="nounderline abstract_t">LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int 2022; 33:2049.</a></li><li><a class="nounderline abstract_t">Ferrari S, Bianchi ML, Eisman JA, et al. Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 2012; 23:2735.</a></li><li><a class="nounderline abstract_t">Peris P, Monegal A, Martínez MA, et al. Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis. Clin Rheumatol 2007; 26:958.</a></li><li><a class="nounderline abstract_t">Cohen A, Liu XS, Stein EM, et al. Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2009; 94:4351.</a></li><li><a class="nounderline abstract_t">Cohen A, Dempster DW, Recker RR, et al. Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2011; 96:3095.</a></li><li><a class="nounderline abstract_t">Mora S, Gilsanz V. Establishment of peak bone mass. Endocrinol Metab Clin North Am 2003; 32:39.</a></li><li><a class="nounderline abstract_t">Berger C, Goltzman D, Langsetmo L, et al. Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res 2010; 25:1948.</a></li><li><a class="nounderline abstract_t">Theintz G, Buchs B, Rizzoli R, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992; 75:1060.</a></li><li><a class="nounderline abstract_t">Bachrach LK, Hastie T, Wang MC, et al. Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 1999; 84:4702.</a></li><li><a class="nounderline abstract_t">Baxter-Jones AD, Faulkner RA, Forwood MR, et al. Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass. J Bone Miner Res 2011; 26:1729.</a></li><li><a class="nounderline abstract_t">Recker RR, Davies KM, Hinders SM, et al. Bone gain in young adult women. JAMA 1992; 268:2403.</a></li><li><a class="nounderline abstract_t">Tenenhouse A, Joseph L, Kreiger N, et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2000; 11:897.</a></li><li><a class="nounderline abstract_t">Löfman O, Larsson L, Toss G. Bone mineral density in diagnosis of osteoporosis: reference population, definition of peak bone mass, and measured site determine prevalence. J Clin Densitom 2000; 3:177.</a></li><li><a class="nounderline abstract_t">Mein AL, Briffa NK, Dhaliwal SS, Price RI. Lifestyle influences on 9-year changes in BMD in young women. J Bone Miner Res 2004; 19:1092.</a></li><li><a class="nounderline abstract_t">Sowers MR, Jannausch M, McConnell D, et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 2006; 91:1261.</a></li><li><a class="nounderline abstract_t">Bainbridge KE, Sowers MF, Crutchfield M, et al. Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am J Epidemiol 2002; 156:410.</a></li><li><a class="nounderline abstract_t">Melton LJ 3rd, Atkinson EJ, O'Connor MK, et al. Determinants of bone loss from the femoral neck in women of different ages. J Bone Miner Res 2000; 15:24.</a></li><li><a class="nounderline abstract_t">Chapurlat RD, Garnero P, Sornay-Rendu E, et al. Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporos Int 2000; 11:493.</a></li><li><a class="nounderline abstract_t">Sowers M, Crutchfield M, Bandekar R, et al. Bone mineral density and its change in pre-and perimenopausal white women: the Michigan Bone Health Study. J Bone Miner Res 1998; 13:1134.</a></li><li><a class="nounderline abstract_t">Slemenda C, Longcope C, Peacock M, et al. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 1996; 97:14.</a></li><li><a class="nounderline abstract_t">Berger C, Langsetmo L, Joseph L, et al. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ 2008; 178:1660.</a></li><li><a class="nounderline abstract_t">Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab 2008; 93:861.</a></li><li><a class="nounderline abstract_t">Sowers MR, Zheng H, Jannausch ML, et al. Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J Clin Endocrinol Metab 2010; 95:2155.</a></li><li><a class="nounderline abstract_t">Iki M, Morita A, Ikeda Y, et al. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 2006; 17:1086.</a></li><li><a class="nounderline abstract_t">Seifert-Klauss V, Link T, Heumann C, et al. Influence of pattern of menopausal transition on the amount of trabecular bone loss. Results from a 6-year prospective longitudinal study. Maturitas 2006; 55:317.</a></li><li><a class="nounderline abstract_t">Greendale GA, Sowers M, Han W, et al. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res 2012; 27:111.</a></li><li><a class="nounderline abstract_t">Macdonald HM, New SA, Campbell MK, Reid DM. Influence of weight and weight change on bone loss in perimenopausal and early postmenopausal Scottish women. Osteoporos Int 2005; 16:163.</a></li><li><a class="nounderline abstract_t">Thompson PW, Taylor J, Dawson A. The annual incidence and seasonal variation of fractures of the distal radius in men and women over 25 years in Dorset, UK. Injury 2004; 35:462.</a></li><li><a class="nounderline abstract_t">Melton LJ 3rd, Amadio PC, Crowson CS, O'Fallon WM. Long-term trends in the incidence of distal forearm fractures. Osteoporos Int 1998; 8:341.</a></li><li><a class="nounderline abstract_t">Hosmer WD, Genant HK, Browner WS. Fractures before menopause: a red flag for physicians. Osteoporos Int 2002; 13:337.</a></li><li><a class="nounderline abstract_t">Wu F, Mason B, Horne A, et al. Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures. Arch Intern Med 2002; 162:33.</a></li><li><a class="nounderline abstract_t">Hsu YH, Venners SA, Terwedow HA, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 2006; 83:146.</a></li><li><a class="nounderline abstract_t">Goulding A, Gold E, Walker R, Lewis-Barned N. Women with past history of bone fracture have low spinal bone density before menopause. N Z Med J 1997; 110:232.</a></li><li><a class="nounderline abstract_t">Fiorano-Charlier C, Ostertag A, Aquino JP, et al. Reduced bone mineral density in postmenopausal women self-reporting premenopausal wrist fractures. Bone 2002; 31:102.</a></li><li><a class="nounderline abstract_t">Lauder TD, Dixit S, Pezzin LE, et al. The relation between stress fractures and bone mineral density: evidence from active-duty Army women. Arch Phys Med Rehabil 2000; 81:73.</a></li><li><a class="nounderline abstract_t">Wigderowitz CA, Cunningham T, Rowley DI, et al. Peripheral bone mineral density in patients with distal radial fractures. J Bone Joint Surg Br 2003; 85:423.</a></li><li><a class="nounderline abstract_t">Hung LK, Wu HT, Leung PC, Qin L. Low BMD is a risk factor for low-energy Colles' fractures in women before and after menopause. Clin Orthop Relat Res 2005; :219.</a></li><li><a class="nounderline abstract_t">Rozental TD, Deschamps LN, Taylor A, et al. Premenopausal women with a distal radial fracture have deteriorated trabecular bone density and morphology compared with controls without a fracture. J Bone Joint Surg Am 2013; 95:633.</a></li><li><a class="nounderline abstract_t">Valentino R, Savastano S, Tommaselli AP, et al. The influence of intense ballet training on trabecular bone mass, hormone status, and gonadotropin structure in young women. J Clin Endocrinol Metab 2001; 86:4674.</a></li><li><a class="nounderline abstract_t">Warren MP, Brooks-Gunn J, Hamilton LH, et al. Scoliosis and fractures in young ballet dancers. Relation to delayed menarche and secondary amenorrhea. N Engl J Med 1986; 314:1348.</a></li><li><a class="nounderline abstract_t">Warren MP, Brooks-Gunn J, Fox RP, et al. Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: a longitudinal study. J Clin Endocrinol Metab 2002; 87:3162.</a></li><li><a class="nounderline abstract_t">Kadel NJ, Teitz CC, Kronmal RA. Stress fractures in ballet dancers. Am J Sports Med 1992; 20:445.</a></li><li><a class="nounderline abstract_t">Gam A, Goldstein L, Karmon Y, et al. Comparison of stress fractures of male and female recruits during basic training in the Israeli anti-aircraft forces. Mil Med 2005; 170:710.</a></li><li><a class="nounderline abstract_t">Shaffer RA, Rauh MJ, Brodine SK, et al. Predictors of stress fracture susceptibility in young female recruits. Am J Sports Med 2006; 34:108.</a></li><li><a class="nounderline abstract_t">Lappe J, Davies K, Recker R, Heaney R. Quantitative ultrasound: use in screening for susceptibility to stress fractures in female army recruits. J Bone Miner Res 2005; 20:571.</a></li><li><a class="nounderline abstract_t">Joy EA, Campbell D. Stress fractures in the female athlete. Curr Sports Med Rep 2005; 4:323.</a></li><li><a class="nounderline abstract_t">Korpelainen R, Orava S, Karpakka J, et al. Risk factors for recurrent stress fractures in athletes. Am J Sports Med 2001; 29:304.</a></li><li><a class="nounderline abstract_t">Cosman F, Ruffing J, Zion M, et al. Determinants of stress fracture risk in United States Military Academy cadets. Bone 2013; 55:359.</a></li><li><a class="nounderline abstract_t">Rozental TD, Johannesdottir F, Kempland KC, Bouxsein ML. Characterization of trabecular bone microstructure in premenopausal women with distal radius fractures. Osteoporos Int 2018; 29:409.</a></li><li><a class="nounderline abstract_t">Cohen A, Liu XS, Stein EM, et al. Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2009; 94:4351.</a></li><li><a class="nounderline abstract_t">Moreira CA, Bilezikian JP. Stress Fractures: Concepts and Therapeutics. J Clin Endocrinol Metab 2017; 102:525.</a></li><li><a class="nounderline abstract_t">Kumagai S, Kawano S, Atsumi T, et al. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases. J Rheumatol 2005; 32:863.</a></li><li><a class="nounderline abstract_t">Borba VZ, Matos PG, da Silva Viana PR, et al. High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 2005; 14:529.</a></li><li><a class="nounderline abstract_t">Honkanen R, Tuppurainen M, Kroger H, et al. Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures. Calcif Tissue Int 1997; 60:327.</a></li><li><a class="nounderline abstract_t">Rothberg AD, Matshidze PK. Perimenopausal wrist fracture--an opportunity for prevention and management of osteoporosis. S Afr Med J 2000; 90:1121.</a></li><li><a class="nounderline abstract_t">Peris P, Guañabens N, Martínez de Osaba MJ, et al. Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum 2002; 32:64.</a></li><li><a class="nounderline abstract_t">Eskandari F, Martinez PE, Torvik S, et al. Low bone mass in premenopausal women with depression. Arch Intern Med 2007; 167:2329.</a></li><li><a class="nounderline abstract_t">Petronijević M, Petronijević N, Ivković M, et al. Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression. Bone 2008; 42:582.</a></li><li><a class="nounderline abstract_t">Altindag O, Altindag A, Asoglu M, et al. Relation of cortisol levels and bone mineral density among premenopausal women with major depression. Int J Clin Pract 2007; 61:416.</a></li><li><a class="nounderline abstract_t">Black AJ, Topping J, Durham B, et al. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 2000; 15:557.</a></li><li><a class="nounderline abstract_t">Naylor KE, Iqbal P, Fledelius C, et al. The effect of pregnancy on bone density and bone turnover. J Bone Miner Res 2000; 15:129.</a></li><li><a class="nounderline abstract_t">Karlsson MK, Ahlborg HG, Karlsson C. Maternity and bone mineral density. Acta Orthop 2005; 76:2.</a></li><li><a class="nounderline abstract_t">Sowers M, Crutchfield M, Jannausch M, et al. A prospective evaluation of bone mineral change in pregnancy. Obstet Gynecol 1991; 77:841.</a></li><li><a class="nounderline abstract_t">Kaur M, Pearson D, Godber I, et al. Longitudinal changes in bone mineral density during normal pregnancy. Bone 2003; 32:449.</a></li><li><a class="nounderline abstract_t">Kovacs CS. Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery. Physiol Rev 2016; 96:449.</a></li><li><a class="nounderline abstract_t">Holmberg-Marttila D, Leino A, Sievänen H. Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses. Osteoporos Int 2003; 14:103.</a></li><li><a class="nounderline abstract_t">Sowers M, Corton G, Shapiro B, et al. Changes in bone density with lactation. JAMA 1993; 269:3130.</a></li><li><a class="nounderline abstract_t">Kolthoff N, Eiken P, Kristensen B, Nielsen SP. Bone mineral changes during pregnancy and lactation: a longitudinal cohort study. Clin Sci (Lond) 1998; 94:405.</a></li><li><a class="nounderline abstract_t">Kalkwarf HJ, Specker BL, Bianchi DC, et al. The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med 1997; 337:523.</a></li><li><a class="nounderline abstract_t">Sowers MF, Hollis BW, Shapiro B, et al. Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 1996; 276:549.</a></li><li><a class="nounderline abstract_t">VanHouten JN, Dann P, Stewart AF, et al. Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J Clin Invest 2003; 112:1429.</a></li><li><a class="nounderline abstract_t">Sowers M, Eyre D, Hollis BW, et al. Biochemical markers of bone turnover in lactating and nonlactating postpartum women. J Clin Endocrinol Metab 1995; 80:2210.</a></li><li><a class="nounderline abstract_t">Vajda EG, Bowman BM, Miller SC. Cancellous and cortical bone mechanical properties and tissue dynamics during pregnancy, lactation, and postlactation in the rat. Biol Reprod 2001; 65:689.</a></li><li><a class="nounderline abstract_t">de Bakker CM, Li Y, Zhao H, et al. Structural Adaptations in the Rat Tibia Bone Induced by Pregnancy and Lactation Confer Protective Effects Against Future Estrogen Deficiency. J Bone Miner Res 2018; 33:2165.</a></li><li><a class="nounderline abstract_t">Michaëlsson K, Baron JA, Farahmand BY, Ljunghall S. Influence of parity and lactation on hip fracture risk. Am J Epidemiol 2001; 153:1166.</a></li><li><a class="nounderline abstract_t">Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332:767.</a></li><li><a class="nounderline abstract_t">Alderman BW, Weiss NS, Daling JR, et al. Reproductive history and postmenopausal risk of hip and forearm fracture. Am J Epidemiol 1986; 124:262.</a></li><li><a class="nounderline abstract_t">Cooke-Hubley S, Gao Z, Mugford G, et al. Parity and lactation are not associated with incident fragility fractures or radiographic vertebral fractures over 16 years of follow-up: Canadian Multicentre Osteoporosis Study (CaMos). Arch Osteoporos 2019; 14:49.</a></li><li><a class="nounderline abstract_t">Crandall CJ, Liu J, Cauley J, et al. Associations of Parity, Breastfeeding, and Fractures in the Women's Health Observational Study. Obstet Gynecol 2017; 130:171.</a></li><li><a class="nounderline abstract_t">Kovacs CS, Ralston SH. Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int 2015; 26:2223.</a></li><li><a class="nounderline abstract_t">Hardcastle SA. "Pregnancy and Lactation Associated Osteoporosis". Calcif Tissue Int 2022; 110:531.</a></li><li><a class="nounderline abstract_t">Kondapalli AV, Kamanda-Kosseh M, Williams JM, et al. Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study. Osteoporos Int 2023; 34:1477.</a></li><li><a class="nounderline abstract_t">Hadji P, Boekhoff J, Hahn M, et al. Pregnancy-associated transient osteoporosis of the hip: results of a case-control study. Arch Osteoporos 2017; 12:11.</a></li><li><a class="nounderline abstract_t">Orhadje E, Berg K, Hauser B, Ralston SH. Clinical Features, Incidence and Treatment Outcome in Pregnancy-Associated Osteoporosis: A Single-Centre Experience over Two Decades. Calcif Tissue Int 2023; 113:591.</a></li><li><a class="nounderline abstract_t">Kyvernitakis I, Reuter TC, Hellmeyer L, et al. Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. Osteoporos Int 2018; 29:135.</a></li><li><a class="nounderline abstract_t">Dunne F, Walters B, Marshall T, Heath DA. Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) 1993; 39:487.</a></li><li><a class="nounderline abstract_t">Laroche M, Talibart M, Cormier C, et al. Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature. Osteoporos Int 2017; 28:3135.</a></li><li><a class="nounderline abstract_t">Qian Y, Wang L, Yu L, Huang W. Pregnancy- and lactation-associated osteoporosis with vertebral fractures: a systematic review. BMC Musculoskelet Disord 2021; 22:926.</a></li><li><a class="nounderline abstract_t">Heshmati HM, Khosla S. Idiopathic osteoporosis: a heterogeneous entity. Ann Med Interne (Paris) 1998; 149:77.</a></li><li><a class="nounderline abstract_t">Rizzoli R, Bonjour JP. Pregnancy-associated osteoporosis. Lancet 1996; 347:1274.</a></li><li><a class="nounderline abstract_t">Scioscia MF, Vidal M, Sarli M, et al. Severe Bone Microarchitecture Impairment in Women With Pregnancy and Lactation-Associated Osteoporosis. J Endocr Soc 2021; 5:bvab031.</a></li><li><a class="nounderline abstract_t">Peris P, Guañabens N, Monegal A, et al. Pregnancy associated osteoporosis: the familial effect. Clin Exp Rheumatol 2002; 20:697.</a></li><li><a class="nounderline abstract_t">Butscheidt S, Tsourdi E, Rolvien T, et al. Relevant genetic variants are common in women with pregnancy and lactation-associated osteoporosis (PLO) and predispose to more severe clinical manifestations. Bone 2021; 147:115911.</a></li><li><a class="nounderline abstract_t">Campos-Obando N, Oei L, Hoefsloot LH, et al. Osteoporotic vertebral fractures during pregnancy: be aware of a potential underlying genetic cause. J Clin Endocrinol Metab 2014; 99:1107.</a></li><li><a class="nounderline abstract_t">Cook FJ, Mumm S, Whyte MP, Wenkert D. Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism. J Bone Miner Res 2014; 29:922.</a></li><li><a class="nounderline abstract_t">Cohen A, Kamanda-Kosseh M, Dempster DW, et al. Women With Pregnancy and Lactation-Associated Osteoporosis (PLO) Have Low Bone Remodeling Rates at the Tissue Level. J Bone Miner Res 2019; 34:1552.</a></li><li><a class="nounderline abstract_t">Phillips AJ, Ostlere SJ, Smith R. Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int 2000; 11:449.</a></li><li><a class="nounderline abstract_t">Gehlen M, Lazarescu AD, Hinz C, et al. Long-term outcome of patients with pregnancy and lactation-associated osteoporosis (PLO) with a particular focus on quality of life. Clin Rheumatol 2019; 38:3575.</a></li><li><a class="nounderline abstract_t">Peltz-Sinvani N, Raz HM, Klein P, et al. Pregnancy- and lactation-induced osteoporosis: a social-media-based survey. BMC Pregnancy Childbirth 2023; 23:311.</a></li><li><a class="nounderline abstract_t">Khosla S, Lufkin EG, Hodgson SF, et al. Epidemiology and clinical features of osteoporosis in young individuals. Bone 1994; 15:551.</a></li><li><a class="nounderline abstract_t">Reed BY, Zerwekh JE, Sakhaee K, et al. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 1995; 10:1218.</a></li><li><a class="nounderline abstract_t">Pepene CE, Seck T, Diel I, et al. Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis. Exp Clin Endocrinol Diabetes 2004; 112:38.</a></li><li><a class="nounderline abstract_t">Rubin MR, Schussheim DH, Kulak CA, et al. Idiopathic osteoporosis in premenopausal women. Osteoporos Int 2005; 16:526.</a></li><li><a class="nounderline abstract_t">Peris P, Ruiz-Esquide V, Monegal A, et al. Idiopathic osteoporosis in premenopausal women. Clinical characteristics and bone remodelling abnormalities. Clin Exp Rheumatol 2008; 26:986.</a></li><li><a class="nounderline abstract_t">Donovan MA, Dempster D, Zhou H, et al. Low bone formation in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2005; 90:3331.</a></li><li><a class="nounderline abstract_t">Goetz TG, Nair N, Shiau S, et al. In premenopausal women with idiopathic osteoporosis, lower bone formation rate is associated with higher body fat and higher IGF-1. Osteoporos Int 2022; 33:659.</a></li><li><a class="nounderline abstract_t">Rolvien T, Stürznickel J, Schmidt FN, et al. Comparison of Bone Microarchitecture Between Adult Osteogenesis Imperfecta and Early-Onset Osteoporosis. Calcif Tissue Int 2018; 103:512.</a></li><li><a class="nounderline abstract_t">Hartikka H, Mäkitie O, Männikkö M, et al. Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J Bone Miner Res 2005; 20:783.</a></li><li><a class="nounderline abstract_t">Butscheidt S, Delsmann A, Rolvien T, et al. Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2. Osteoporos Int 2018; 29:1643.</a></li><li><a class="nounderline abstract_t">Stürznickel J, Rolvien T, Delsmann A, et al. Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early-Onset Osteoporosis (EOOP). J Bone Miner Res 2021; 36:271.</a></li></ol></div><div id="topicVersionRevision">Topic 2058 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30283887" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Primary Osteoporosis in Young Adults: Genetic Basis and Identification of Novel Variants in Causal Genes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34743040" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7976495" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The diagnosis of osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7976495" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The diagnosis of osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32453819" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35478046" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The clinician's guide to prevention and treatment of osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22684497" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Osteoporosis in young adults: pathophysiology, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16941198" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19837923" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21832117" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12699292" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Establishment of peak bone mass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20499378" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1400871" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10599739" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21520276" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1404797" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Bone gain in young adult women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11199195" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10871911" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Bone mineral density in diagnosis of osteoporosis: reference population, definition of peak bone mass, and measured site determine prevalence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15176991" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Lifestyle influences on 9-year changes in BMD in young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16403818" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Hormone predictors of bone mineral density changes during the menopausal transition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12196310" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Natural history of bone loss over 6 years among premenopausal and early postmenopausal women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10646111" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Determinants of bone loss from the femoral neck in women of different ages.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10982164" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9661077" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Bone mineral density and its change in pre-and perimenopausal white women: the Michigan Bone Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8550826" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18559803" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18160467" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Bone mineral density changes during the menopause transition in a multiethnic cohort of women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20215399" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16758145" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16781095" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Influence of pattern of menopausal transition on the amount of trabecular bone loss. Results from a 6-year prospective longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21976317" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15185065" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Influence of weight and weight change on bone loss in perimenopausal and early postmenopausal Scottish women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15081322" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The annual incidence and seasonal variation of fractures of the distal radius in men and women over 25 years in Dorset, UK.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10024904" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Long-term trends in the incidence of distal forearm fractures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12030549" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Fractures before menopause: a red flag for physicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11784217" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16400063" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9236807" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Women with past history of bone fracture have low spinal bone density before menopause.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12110420" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Reduced bone mineral density in postmenopausal women self-reporting premenopausal wrist fractures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10638880" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The relation between stress fractures and bone mineral density: evidence from active-duty Army women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12729122" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Peripheral bone mineral density in patients with distal radial fractures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15930942" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Low BMD is a risk factor for low-energy Colles' fractures in women before and after menopause.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23553299" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Premenopausal women with a distal radial fracture have deteriorated trabecular bone density and morphology compared with controls without a fracture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11600524" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The influence of intense ballet training on trabecular bone mass, hormone status, and gonadotropin structure in young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3451741" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Scoliosis and fractures in young ballet dancers. Relation to delayed menarche and secondary amenorrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12107218" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: a longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1357994" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Stress fractures in ballet dancers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16173215" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Comparison of stress fractures of male and female recruits during basic training in the Israeli anti-aircraft forces.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16170040" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Predictors of stress fracture susceptibility in young female recruits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15765175" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Quantitative ultrasound: use in screening for susceptibility to stress fractures in female army recruits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16282034" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Stress fractures in the female athlete.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11394600" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Risk factors for recurrent stress fractures in athletes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23624291" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Determinants of stress fracture risk in United States Military Academy cadets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29101409" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Characterization of trabecular bone microstructure in premenopausal women with distal radius fractures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19837923" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27732325" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Stress Fractures: Concepts and Therapeutics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15868623" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16130509" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9075627" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11196034" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Perimenopausal wrist fracture--an opportunity for prevention and management of osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12219322" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18039992" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Low bone mass in premenopausal women with depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18226593" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17313608" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Relation of cortisol levels and bone mineral density among premenopausal women with major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10750571" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10646122" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The effect of pregnancy on bone density and bone turnover.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15788303" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Maternity and bone mineral density.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2030854" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : A prospective evaluation of bone mineral change in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12689690" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Longitudinal changes in bone mineral density during normal pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26887676" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12730783" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8505816" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Changes in bone density with lactation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9640346" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Bone mineral changes during pregnancy and lactation: a longitudinal cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9262495" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The effect of calcium supplementation on bone density during lactation and after weaning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8709404" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Elevated parathyroid hormone-related peptide associated with lactation and bone density loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14597768" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7608281" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Biochemical markers of bone turnover in lactating and nonlactating postpartum women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11514329" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Cancellous and cortical bone mechanical properties and tissue dynamics during pregnancy, lactation, and postlactation in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30040148" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Structural Adaptations in the Rat Tibia Bone Induced by Pregnancy and Lactation Confer Protective Effects Against Future Estrogen Deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11415951" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Influence of parity and lactation on hip fracture risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7862179" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3728442" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Reproductive history and postmenopausal risk of hip and forearm fracture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31037359" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Parity and lactation are not associated with incident fragility fractures or radiographic vertebral fractures over 16 years of follow-up: Canadian Multicentre Osteoporosis Study (CaMos).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28594759" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Associations of Parity, Breastfeeding, and Fractures in the Women's Health Observational Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25939309" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Presentation and management of osteoporosis presenting in association with pregnancy or lactation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33620518" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : "Pregnancy and Lactation Associated Osteoporosis".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37204454" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28110481" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Pregnancy-associated transient osteoporosis of the hip: results of a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37819437" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Clinical Features, Incidence and Treatment Outcome in Pregnancy-Associated Osteoporosis: A Single-Centre Experience over Two Decades.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28965212" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8287577" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Pregnancy associated osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28879474" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34732196" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Pregnancy- and lactation-associated osteoporosis with vertebral fractures: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11490528" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Idiopathic osteoporosis: a heterogeneous entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8622498" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Pregnancy-associated osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33860131" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Severe Bone Microarchitecture Impairment in Women With Pregnancy and Lactation-Associated Osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12412203" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Pregnancy associated osteoporosis: the familial effect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33716164" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Relevant genetic variants are common in women with pregnancy and lactation-associated osteoporosis (PLO) and predispose to more severe clinical manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24423337" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Osteoporotic vertebral fractures during pregnancy: be aware of a potential underlying genetic cause.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24014470" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31348548" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Women With Pregnancy and Lactation-Associated Osteoporosis (PLO) Have Low Bone Remodeling Rates at the Tissue Level.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10912848" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Pregnancy-associated osteoporosis: does the skeleton recover?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31468224" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Long-term outcome of patients with pregnancy and lactation-associated osteoporosis (PLO) with a particular focus on quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37131133" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Pregnancy- and lactation-induced osteoporosis: a social-media-based survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7980966" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Epidemiology and clinical features of osteoporosis in young individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8585426" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14758570" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15300364" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Idiopathic osteoporosis in premenopausal women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19210860" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Idiopathic osteoporosis in premenopausal women. Clinical characteristics and bone remodelling abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15784712" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Low bone formation in premenopausal women with idiopathic osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34665288" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : In premenopausal women with idiopathic osteoporosis, lower bone formation rate is associated with higher body fat and higher IGF-1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29946973" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Comparison of Bone Microarchitecture Between Adult Osteogenesis Imperfecta and Early-Onset Osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15824851" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29594386" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33118644" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early-Onset Osteoporosis (EOOP).</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
